Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial - Wikidata - wikimedia - TriplyDB

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

http://www.wikidata.org/entity/Q36634556

about

Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake Statistical controversies in clinical research: long-term follow-up of clinical trials in cancer Molecular cancer prevention: Current status and future directions Chemoprevention of cancer: current evidence and future prospects Physician and Patient Barriers to Breast Cancer Preventive Therapy Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis.Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testing.Ongoing data from the breast cancer prevention trials: opportunity for breast cancer risk reduction.Synthesis and biological evaluation of novel tamoxifen-1,2,4-triazole conjugates.Antiestrogen use reduces risk of cervical neoplasia in breast cancer patients: a population-based study.How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?Antioxidant, Anti-inflammatory, and Genomic Stability Enhancement Effects of Zinc l-carnosine: A Potential Cancer Chemopreventive Agent?Report from the 37th san antonio breast cancer symposium, 9-13th december 2014, Texas, USA.Primary chemoprevention of breast cancer: Are the adverse effects too burdensome?Can the breast screening appointment be used to provide risk assessment and prevention advice?Chemoprevention for Breast Cancer.Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors.Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials.Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers.Impact of preventive therapy on the risk of breast cancer among women with benign breast disease.Tamoxifen use and acute pancreatitis: A population-based cohort study.Barriers and Facilitators to Patient-Provider Communication When Discussing Breast Cancer Risk to Aid in the Development of Decision Support Tools.Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial Cancer Prevention: Obstacles, Challenges and the Road Ahead.Adipokines and Vascular Endothelial Growth Factor in Normal Human Breast Tissue in Vivo - Correlations and Attenuation by Dietary Flaxseed.Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.Contribution of the Unified Health Care System to mammography screening in Brazil, 2013.Breast Cancer Profile among Patients with a History of Chemoprevention.Decision making for breast cancer prevention among women at elevated risk Role of ER-α36 in breast cancer by typical xenoestrogens.Genetic screening for gynecological cancer: where are we heading?Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment.Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I).The selective estrogen receptor modulators in breast cancer prevention.Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ.Endocrine therapy for breast cancer prevention in high-risk women: clinical and economic considerations.

P2860

Q26773464-00372D0E-3B8B-49C0-89DB-015680181452 Q26774593-4CFAA0DB-112A-486B-A887-082F0D48F81D Q26782494-A46B4053-56F8-47FB-86EA-00C897C7E8FC Q26797207-0F6C30BB-0B81-4420-8B54-A235B656BD15 Q27000363-D2600140-3580-4809-8F55-4374E31EF903 Q28072526-CE18C30D-CC5C-4795-8D22-53F5AA074C30 Q28074177-9A42493D-7370-4ADF-8255-87204B7CD15A Q28269986-FAA0CF48-3563-48BD-B4A2-DEF485902C48 Q30234123-58D84636-5927-4CCB-9F40-BBD3F49BEE46 Q30234614-1FE4E642-F53D-4206-8BA7-CAE8D20E516F Q30936399-DDFC6B73-E6E3-4486-803D-94EC38D38EB3 Q31106602-D11640BD-B1DA-4227-961B-632E4AAE5FA4 Q33710124-6780DC67-2A22-48BE-98D7-8354351CD6B9 Q33767120-85E57CF9-04F5-4965-B28C-BDB7EABC2307 Q34549429-0F18CC11-510B-466F-94A4-9DCE00CCF8C9 Q35106174-3D60BDE0-CF08-4831-A740-F03573C2A1D6 Q35744037-3BAE2318-EB68-4839-92A3-96D4CF4E0977 Q35834376-40642494-FBA6-416D-9369-1CB4EBC88966 Q35998680-86EB829B-6D3B-419B-BCB9-8AD124DA1427 Q36048136-38E95F0F-7B70-4FB2-8546-55603B5B1DE2 Q36112872-0994256D-69F7-4EA1-BCEA-AD262D3B5F18 Q36229869-29CE5F2C-59B9-4EED-96B8-2A4CC1C6FB4E Q36252676-15DE0584-24AB-4E25-8789-CA5D758ADB24 Q36258270-D29DADD8-252C-4912-A98A-106D35A85477 Q36307581-25F01A6A-0BF0-445F-BE06-33E145593CF0 Q36613582-00172B48-6074-491D-9C00-EF7FCDF1A6CF Q36625021-25F4FB1F-F17C-4FE5-A812-CE070AB3A95E Q37002946-7EA63AEE-22A3-40F0-BAC5-582FB5F9D7C4 Q37067165-692B74EE-BFBE-473F-88E3-B524CC82D1B1 Q37085141-43BD8223-5411-44E3-9D6D-BE41C1575569 Q37392230-06131838-757C-436F-87CE-1B52FBBA40EF Q37547625-95D0D790-90A7-4E1D-8525-FD097FBDB5D2 Q37720955-BF1827C5-D334-4EAE-83C5-3F0118A342BA Q38580235-DCB40D3C-BBF7-448A-9CFC-4DF01C53CBAD Q38659935-33026654-35C3-44B3-ACAF-265BF1CF92C9 Q38669803-D02280AC-8C7F-4766-A0AE-893CD5556FCB Q38702563-76E4EA41-F407-41C6-A61A-1ECA9D60C56E Q38703578-F50C0F8E-8945-40BA-AF10-FD90221A7487 Q38727084-C49336D4-788C-4C13-8265-EAA360616F1B Q38753738-381D6A22-7A70-4D42-8997-017DBE6E4241

P2860

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

http://www.wikidata.org/entity/Q36634556

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Tamoxifen for prevention of br ...... breast cancer prevention trial

@ast

Tamoxifen for prevention of br ...... breast cancer prevention trial

@en

type

label

Tamoxifen for prevention of br ...... breast cancer prevention trial

@ast

Tamoxifen for prevention of br ...... breast cancer prevention trial

@en

prefLabel

Tamoxifen for prevention of br ...... breast cancer prevention trial

@ast

Tamoxifen for prevention of br ...... breast cancer prevention trial

@en

P1433

Q36634556-5BE53500-3857-4CC3-98ED-0A8816E09EC7

P1476

Q36634556-594B33D8-1070-43D3-BFD8-BF5C45D1F37E

P2093

Q36634556-05B5755D-A10C-402E-A65E-F016C949B19B

Q36634556-0CB93330-8137-40A1-9394-A2598A962707

Q36634556-20E1CC4A-9EF4-41AC-8BCB-2F2BDA0C9381

Q36634556-23DE5421-7C39-41A5-89C1-06141497086F

Q36634556-26E63277-9F74-407C-96CD-FEA31A1A238E

Q36634556-5D41333F-BFD7-4F51-BF53-431D3C4710EE

Q36634556-BE38F744-59AD-4F7A-BE40-CC9FA0383A1B

P2860

Q36634556-17163779-2D7E-4799-BFC1-CAE6DB41E7A6

Q36634556-1F7BE9D3-6991-43F7-AE7A-AFD12DC05CE5

Q36634556-4608762D-0062-4D3F-97D8-7C81DFBDA4DF

Q36634556-47C9EB4B-A42F-402B-8565-AD237190BB9E

Q36634556-4E72E711-287D-4AB7-9543-60C6F2B4C813

Q36634556-4F23CFE9-FBF7-42A2-8658-8F2338382390

Q36634556-5C846105-26CF-4A94-A20C-F5F921D393E3

Q36634556-61D27D36-607D-447A-9757-53D1C036B970

Q36634556-69863B2C-5803-4568-8458-A955F599EE03

Q36634556-A4E48B1D-310F-4B27-9585-D115FA3FC87F

P304

Q36634556-F9AFA958-308D-45EF-98BE-57E72AE22DD3

P31

Q36634556-DC8288C7-5DCB-4069-B72B-2C7BAD34521C

P356

Q36634556-ED102010-404F-45E3-A735-B5CEF3543016

P433

Q36634556-94782530-127B-4BBB-B4AB-1442277DBCC0

P478

Q36634556-73FA1FBD-BFB2-4F29-98F6-2EB2F9C3EFA3

P50

Q36634556-2565073C-1880-4313-9FFE-3D0FA7E445CB

P577

Q36634556-C1F30A4F-187B-466B-A251-DDA122442B05

P698

Q36634556-20D01216-6BD9-4E05-9B2B-BC953893A631

P932

Q36634556-FFD743B6-255E-418D-A6A3-6FD7774BCB71

P356

S1470-2045(14)71171-4

P1433

The Lancet Oncology

P1476

Tamoxifen for prevention of br ...... breast cancer prevention trial

@en

P2093

Hisham Hamed

http://www.w3.org/2001/XMLSchema#string

IBIS-I Investigators

http://www.w3.org/2001/XMLSchema#string

Ivana Sestak

http://www.w3.org/2001/XMLSchema#string

Jack Cuzick

http://www.w3.org/2001/XMLSchema#string

John F Forbes

http://www.w3.org/2001/XMLSchema#string

Kaija Holli

http://www.w3.org/2001/XMLSchema#string

Simon Cawthorn

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy

Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.

Overview of the main outcomes in breast-cancer prevention trials.

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study.

P304

67-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1470-2045(14)71171-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25497694

http://www.w3.org/2001/XMLSchema#string

P932

4772450

http://www.w3.org/2001/XMLSchema#string